A busy session for small-cap corporate activity was headlined by Thalia Therapeutics' transformative acquisition of an RNA oncology company, backed by an oversubscribed fundraise, while Vertu Motors lifted full-year profit guidance on broad trading strength and a M&A deadline loomed over CyanConnode. Across the broader universe, deal-making, regulatory milestones, and strategic pivots dominated the news flow, from a recommended all-cash bid for Pharos Energy to Verici Dx completing US nationwide lab authorisation.
Thalia Therapeutics acquires RNA oncology firm in oversubscribed £2.75m raise
Thalia Therapeutics (AIM:THAT) is acquiring Sanmirna Therapeutics, adding clinical-stage RNA therapy miRisten, targeting acute myeloid leukaemia, to its pipeline. The deal is funded by a placing at 0.6p per share that was oversubscribed, raising £2.75m, with the shares responding by jumping 21.74% to 0.7p. The acquisition marks a significant step-up in Thalia's oncology ambitions, bringing a differentiated RNA-based asset into a pipeline that had previously lacked a clinical-stage programme.
Prologis goes public with £12.6bn all-share approach for Segro
United Oil & Gas (AIM:UOG) edged up 1.71% to 0.178p on the session. The broader market backdrop was shaped by a major logistics sector development: US warehouse giant Prologis went public with a £12.6bn all-share takeover proposal for Segro after the UK REIT's board rejected the approach, with Prologis urging shareholders to pressure Segro into formal talks. The move represents one of the largest cross-border real estate bids in recent memory and sets up a potential contested process.
Esyasoft given until 21 July to decide on CyanConnode bid
CyanConnode Holdings (AIM:CYAN) saw its shares slip 2.32% to 8.205p as the put-up-or-shut-up deadline for Esyasoft's possible offer was extended by nearly four weeks to 21 July. The extension reflects confirmatory due diligence reaching its final stages, keeping the potential bid alive while prolonging uncertainty for shareholders. Esyasoft must either announce a firm intention to make an offer or walk away by the new deadline.
Vertu Motors upgrades FY27 profit guidance on broad trading beat
Vertu Motors (AIM:VTU) lifted full-year profit guidance after like-for-like volume growth across all sales channels outpaced expectations, with the group now expecting FY27 adjusted profit before tax to exceed the £24.5m analyst consensus. The shares gained 2.75% to 75.008p. The upgrade underlines the resilience of the UK's used and new car retail market, with Vertu's diversified channel mix, spanning retail, fleet, and aftersales, all contributing to the beat.
Pennant International closes first Auxilium-GenS sale via Siemens channel
Pennant International Group (AIM:PEN) completed its first commercial sale of Auxilium-GenS through its global distribution partnership with Siemens Digital Industries Software, less than three months after the agreement was signed. The milestone validates the commercial potential of the channel arrangement and demonstrates early traction for the systems support software product in the defence and industrial training market. Shares were broadly flat at 25.9p, down a marginal 0.38%.
Seed Innovations pivots to robotics and AI with two post-period deals
Seed Innovations (AIM:SEED) has repositioned its investment strategy toward physical AI and industrial robotics, completing two investments under the new mandate after its year end. The AIM-listed closed-end vehicle, backed by investor Jim Mellon, is stepping away from its prior focus areas to target what it sees as a structural growth opportunity in automation and intelligent systems. Shares were quoted at 2.95p with no change recorded on the session.
Dillistone targets summer CEO hire as Talentis nears cash generation
Dillistone Group (AIM:DSG) rose 4.57% to 10.98p after the recruitment software group signalled that its Talentis platform is on course to turn cash generative in the second half of the year, while a new chief executive is expected to be appointed over the summer. The dual update, operational progress on the group's growth product combined with leadership clarity, provided a positive catalyst for a stock that has been in transition. Outgoing CEO Giles Fearnley and incoming hire Matthias Riechert are central to the handover process.
Verici Dx secures New York approval to complete all-50-states US coverage
Verici Dx (AIM:VRCI) gained 5.33% to 0.395p after securing New York State laboratory certification for its Tutivia kidney transplant rejection test, completing authorisation across all 50 US states. New York's certification requirements are among the most stringent in the country, making the approval a meaningful commercial and regulatory milestone. The nationwide coverage positions Verici to pursue transplant centre partnerships across the full US market without geographic restriction.
Thor Energy awards seismic contract at South Australia hydrogen project
Thor Energy (AIM:THR) signed a Letter of Award for a 464-kilometre 2D seismic survey at its HY-Range natural hydrogen and helium project in South Australia, a key step toward identifying viable drill targets. The contract award advances the project toward its next substantive technical phase, though the shares fell 6.42% to 0.5615p on the session. The survey data will inform the geological model and help prioritise locations for the eventual drilling campaign.
SatoshiPay hits $3m monthly FX volume on Base blockchain migration
Blue Star Capital (AIM:BLU) rose 3.7% to 7.0p after investee company SatoshiPay reported reaching $3m in monthly foreign exchange volume following its migration to the Base blockchain network. SatoshiPay has also launched payment corridors across four markets in the Americas, expanding the commercial footprint of its decentralised FX infrastructure. The milestone represents a meaningful scaling moment for the platform and a positive read-across for Blue Star's portfolio valuation.
Hydrogen Utopia outlines £800m UK SAF plant and defence fuel talks
Hydrogen Utopia International (AIM:HUI) advanced 3.57% to 2.9p after setting out plans for a UK sustainable aviation fuel facility carrying an estimated £800m capital expenditure, alongside early-stage defence fuel discussions through its Fortress Fuel vehicle and continued engagement in Saudi Arabia and Oman. The update spans multiple strategic threads simultaneously, reflecting the company's effort to build a pipeline of large-scale clean fuel projects across both commercial aviation and defence procurement channels.
Zinc Media sells Brexit documentary across North America, Middle East, and Ireland
Zinc Media Group (AIM:ZIN) edged up 1.79% to 57.0p as its Zinc Distribution arm closed licensing deals across multiple territories for a two-part Brexit documentary, with broadcaster agreements in North America, the Middle East, and Ireland already secured and further deals expected. The documentary features prominent political figures including Jeremy Corbyn, David Cameron, Boris Johnson, Nigel Farage, Michael Gove, George Osborne, and Gordon Brown, lending it significant broadcast appeal. The multi-territory sale demonstrates the commercial reach of Zinc's distribution operation beyond its UK production base.
Haydale revenue surges 463% after SaveMoneyCutCarbon acquisition
Haydale (AIM:HAYD) reported a near-fivefold jump in first-half revenue following the January acquisition of SaveMoneyCutCarbon (SMCC), a transformative deal that has fundamentally reshaped the group's scale and business mix. Operating losses widened as integration costs weighed on the bottom line, and the shares fell 3.12% to 0.31p. The revenue surge reflects SMCC's contribution to the consolidated numbers rather than organic growth, and the market's attention will now turn to how quickly integration synergies can offset the near-term cost drag.
Cavendish revenue edges higher but core profit dips in FY March 2026
Cavendish (AIM:CAV) grew full-year revenue marginally to £56.9m in the year ended March 2026, but core profit declined as anticipated larger private markets fees failed to materialise. The result illustrates the uneven recovery in UK capital markets activity, with the AIM-focused investment bank navigating a subdued deal environment. Shares fell 3.24% to 8.95p.
Cobra Resources defines 5km high-grade rare earth zone at Head Prospect
Cobra Resources (AIM:COBR) released new drilling assays from its South Australian rare earth project that outline a scalable mineralised system extending across a 5-kilometre high-grade zone at the Head Prospect. Acid-generating characteristics identified in the results could materially reduce extraction costs, a potentially significant economic differentiator for the project. Shares slipped 1.91% to 4.365p on the session despite the technically positive update.
Ratio Petroleum launches recommended all-cash bid for Pharos Energy
Pharos Energy (AIM:PHAR) received a recommended all-cash takeover approach from Israel-based Ratio Petroleum Energy, structured as a scheme of arrangement. Ratio cited the combined group's capacity to fund exploration growth as a strategic rationale for the deal, which has the backing of Pharos's board. Shares were up 0.7% to 25.577p, with the muted move suggesting the market had partially anticipated consolidation in the sector. The scheme structure means shareholder approval will be required to complete the transaction.
Jadestone Malaysia well flows at 3,000 bopd and triggers third drill decision
Jadestone Energy (AIM:JSE) reported that the first well of its 2026 Malaysia drilling campaign flowed at 3,000 barrels of oil per day, with strong subsurface data from the well prompting a decision to add a third well to the programme. Full-year capital expenditure guidance was left unchanged, indicating the additional well will be accommodated within the existing budget. Shares rose 3.18% to 28.3755p, with the operational success reinforcing confidence in the Malaysia asset base.
Buccaneer Energy reserves rise 18% as NPV reaches $11.7m
Buccaneer Energy (AIM:BUCE) published an independent reserves review confirming an 18% increase in proved reserves at its Texas portfolio, with net present value rising to $11.7m. The updated figures support the group's borrowing base with WAFD Bank at $4.45m. Shares were marginally lower at 0.0094p, down 1.05%, with the reserves upgrade providing balance sheet underpinning rather than a near-term trading catalyst.
Beximco Pharma half-year profit climbs 36% on domestic and export strength
Beximco Pharmaceuticals (LSE:BXP) grew profit after tax by more than a third in the six months to December 2025, with acceleration across both its Bangladesh home market and international export business outpacing overall revenue growth. The result demonstrates the operating leverage embedded in the generic pharmaceuticals model as volumes scale. Shares were quoted at 42.5p with no change recorded on the session.
Essentra closes Boteco acquisition at 6.5x EBITDA
Essentra (LSE:ESNT) completed its bolt-on acquisition of Boteco, an Italian mechanical components specialist, at a multiple of 6.5x EBITDA, with earnings per share accretion expected in the first full year of ownership. The deal adds Italian manufacturing capability to Essentra's components division and fits the group's stated strategy of disciplined bolt-on consolidation. Shares edged up 0.55% to 82.851p.
Cambridge Cognition raises minimum £2.5m for regulatory clearances and platform build
Cambridge Cognition Holdings (AIM:COG) launched a fundraise targeting a minimum of £2.5m to fund CE marking and FDA clearance processes alongside paediatric data development and speech recognition enhancements to its digital cognitive assessment platform. The capital raise reflects the regulatory investment required to unlock clinical and commercial adoption in regulated markets. Shares fell 4.35% to 33.0p, a typical dilution-related reaction to the placing announcement.
Kenmare upsizes credit facility to $230m and secures covenant waivers for 2026
Kenmare Resources (LSE:KMR) expanded its revolving credit facility by $30m to $230m and secured covenant waivers for 2026, buying financial headroom during a period of weakness in titanium mineral markets. The facility upsizing provides operational flexibility without requiring equity issuance, though the covenant waivers signal that current commodity pricing is creating pressure against existing financial covenants. Shares fell 2.84% to 193.15p.
ITM Power signs LOI with DB Systemtechnik for green hydrogen FEED study
ITM Power (AIM:ITM) formalised plans with Deutsche Bahn's technical arm DB Systemtechnik through a Letter of Intent to conduct a front-end engineering and design study assessing electrolyser deployment across DB's rail and transport infrastructure. The agreement positions ITM's technology within one of Europe's largest rail operators, with the FEED study representing the structured first step toward a potential commercial supply relationship. Shares edged up 0.75% to 127.248p.
